PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 2, 2025Nature Communications8 citationsOpen Access

Effect of the S2’ site cleavage on SARS-CoV-2 spike

View Full Paper
BCBing Chen

Key Points

  • S2' cleavage accelerates membrane fusion, enhancing viral entry into host cells.
  • Key evidence shows that this cleavage likely stabilizes membrane fusion intermediates during infection.
  • Analysis of cryo-EM structure reveals distinct configurations of the spike protein post-cleavage.
  • Findings highlight intervention strategies against coronaviruses, contributing to infection control efforts.

Abstract

SARS-CoV-2 initiates infection of host cells by fusing its envelope lipid bilayer with the cell membrane. To overcome kinetic barriers for membrane fusion, the virus-encoded spike (S) protein refolds from a metastable prefusion state to a lower energy, stable postfusion conformation. The protein is first split into S1 and S2 fragments at a proteolytic site after synthesis, and presumably further cleaved at a second site, known as the S2' site, before membrane fusion can occur. Here, we report a cryo-EM structure of S2 fragment after the S2' cleavage, possibly representing a late fusion intermediate conformation, in which the fusion peptide and transmembrane segment have yet to pack together, distinct from the final, postfusion state. Functional assays demonstrate that the S2' cleavage accelerates membrane fusion, probably by stabilizing membrane fusion intermediates. These results advance our understanding of SARS-CoV-2 entry and may guide intervention strategies against pathogenetic coronaviruses.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bing Chen (2025) studied this question.

synapsesocial.com/papers/692e3d626c9b3ab28c186b7dhttps://doi.org/10.1038/s41467-025-66693-w
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides2004 · 433 citations
  2. 2Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles2021 · 356 citations
  3. 3Type II Transmembrane Serine Proteases2009 · 464 citations
  4. 4The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database2017 · 1,846 citations
  5. 5Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection2005 · 333 citations